Agios Pharmaceuticals | Capital Social E Reservas



Equity Capital And Reserves Alterar Data
AbbVie USD 3.32B 2.71B 2024-12
Agios Pharmaceuticals USD 1.47B 74.43M 2025-03
Alnylam Pharmaceuticals USD 115.43M 48.35M 2025-03
Amgen USD 6.21B 330M 2025-03
Arrowhead Research USD 52.59M 132.85M 2024-12
Astellas Pharma JPY 1.51T 19.45B 2025-03
AstraZeneca USD 41.04B 168M 2025-03
Bayer EUR 32.04B 1.49B 2024-12
Biogen USD 16.72B 357.1M 2024-12
BioMarin Pharmaceutical USD 5.79B 135.47M 2025-03
Bristol-Myers Squibb USD 17.39B 1.05B 2025-03
Daiichi Sankyo JPY 1.62T 958M 2025-03
Eli Lilly USD 15.85B 1.65B 2025-03
Exelixis USD 2.24B 31.22M 2025-01
Gilead Sciences USD 19.33B 856M 2024-12
GlaxoSmithKline GBP 14.16B 486M 2025-03
Incyte USD 3.67B 219.94M 2025-03
Ionis Pharmaceuticals USD 475.73M 112.62M 2025-03
Merck USD 46.31B 1.81B 2024-12
Moderna USD 10.07B 835M 2025-03
Novartis USD 44.05B 605M 2024-12
Novartis USD 44.05B 729M 2024-12
Pfizer USD 88.2B 4.08B 2024-12
Regeneron Pharmaceuticals USD 29.39B 34M 2025-03
Roche Holding CHF 36.16B 3.28B 2024-12
Sarepta Therapeutics USD 1.53B 306.67M 2024-12
Vertex Pharmaceuticals USD 16.41B 778.7M 2024-12



Agios Pharmaceuticals Capital Social E Reservas - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2025.